Olaf Panknin

703 total citations
15 papers, 319 citations indexed

About

Olaf Panknin is a scholar working on Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Olaf Panknin has authored 15 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Olaf Panknin's work include Asymmetric Synthesis and Catalysis (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Olaf Panknin is often cited by papers focused on Asymmetric Synthesis and Catalysis (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Olaf Panknin collaborates with scholars based in Germany, Sweden and United States. Olaf Panknin's co-authors include Peter Somfai, Lutz F. Tietze, Ingrid Schuberth, Frauke Alves, Markus Berger, Wolfgang Ebert, Hubertus Pietsch, Marcus Bauser, Gregor Jošt and Jessica Lohrke and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Blood.

In The Last Decade

Olaf Panknin

15 papers receiving 307 citations

Peers

Olaf Panknin

OC

MB

RNMI

IC

MC

Masood Hosseini Denmark

Jens Buchardt Denmark

Steve Arns Canada

Christopher D. Hupp United States

Edward C. Lawson United States

Daniel Choi United States

Viola Previtali Denmark

Jeffrey C. Kern United States

Barbara Salom Italy

Debasmita Saha India

Masood Hosseini Denmark

Olaf Panknin

253 ×1.3

OC

147 ×1.2

MB

26 ×0.6

RNMI

39 ×1.0

IC

27 ×0.7

MC

Citations per year, relative to Olaf Panknin Olaf Panknin (= 1×) peers Masood Hosseini

Countries citing papers authored by Olaf Panknin

Since Specialization

Citations

This map shows the geographic impact of Olaf Panknin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Panknin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Panknin more than expected).

Fields of papers citing papers by Olaf Panknin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Panknin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Panknin. The network helps show where Olaf Panknin may publish in the future.

Co-authorship network of co-authors of Olaf Panknin

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Panknin. A scholar is included among the top collaborators of Olaf Panknin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Panknin. Olaf Panknin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Lohrke, Jessica, Markus Berger, Thomas Frenzel, et al.. (2022). Preclinical Profile of Gadoquatrane. Investigative Radiology. 57(10). 629–638. 43 indexed citations

2.

Chaturvedi, Anuhar, Charu Gupta, Razif Gabdoulline, et al.. (2020). Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia. Haematologica. 106(2). 565–573. 27 indexed citations

3.

Panknin, Olaf, Andrea Wagenfeld, Wilhelm Bone, et al.. (2020). Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women. Journal of Medicinal Chemistry. 63(20). 11854–11881. 11 indexed citations

4.

Chaturvedi, Anuhar, Charu Gupta, Razif Gabdoulline, et al.. (2017). Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia. Blood. 130. 1352–1352. 8 indexed citations

5.

Panknin, Olaf, Stefan Pusch, Stefan Kaulfuß, et al.. (2016). Abstract 2645: BAY 1436032: A highly selective, potent and orally available inhibitor of mutant forms of IDH1. Cancer Research. 76(14_Supplement). 2645–2645. 1 indexed citations

6.

Tietze, Lutz F., Olaf Panknin, Felix Major, & Birgit Krewer. (2008). Synthesis of a Novel Pentagastrin‐Drug Conjugate for a Targeted Tumor Therapy. Chemistry - A European Journal. 14(9). 2811–2818. 10 indexed citations

7.

Panknin, Olaf, et al.. (2008). Synthesis of Aryl Glycines by the α Arylation of Weinreb Amides. Angewandte Chemie International Edition. 47(10). 1907–1909. 24 indexed citations

8.

Panknin, Olaf, et al.. (2008). Synthesis of Aryl Glycines by the α Arylation of Weinreb Amides. Angewandte Chemie. 120(10). 1933–1935. 9 indexed citations

9.

Tietze, Lutz F., Olaf Panknin, Birgit Krewer, Felix Major, & Ingrid Schuberth. (2008). Synthesis and Biological Evaluation of a Novel Pentagastrin- Toxin Conjugate Designed for a Targeted Prodrug Monotherapy of Cancer. International Journal of Molecular Sciences. 9(5). 821–837. 6 indexed citations

10.

Panknin, Olaf, et al.. (2007). Lewis Acid Mediated Asymmetric [2,3]-Sigmatropic Rearrangement of Allylic Amines. Scope and Mechanistic Investigation. The Journal of Organic Chemistry. 72(4). 1294–1300. 27 indexed citations

11.

Somfai, Peter & Olaf Panknin. (2007). Investigations of the [2,3]-Sigmatropic Rearrangements of Vinylaziridines and Allylic Amines. Synlett. 2007(8). 1190–1202. 17 indexed citations

12.

Sauer, Sven, et al.. (2006). Synthesis of New Sugar-Based Surfactants and Evaluation of Their Hemolytic Activities. The Journal of Organic Chemistry. 71(9). 3623–3626. 25 indexed citations

13.

Panknin, Olaf, et al.. (2005). Asymmetric [2,3]-Sigmatropic Rearrangement of Allylic Ammonium Ylides. Journal of the American Chemical Society. 127(26). 9352–9353. 38 indexed citations

14.

Tietze, Lutz F., et al.. (2002). Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug This work was supported by the Deutsche Forschungsgemeinschaft (SFB 416) and by the Fonds der Chemischen Industrie.. Angewandte Chemie International Edition. 41(5). 759–759. 46 indexed citations

15.

Tietze, Lutz F., et al.. (2002). Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug. Angewandte Chemie. 114(5). 785–787. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact